EST
BIIB icon

EA Series Trust’s Biogen BIIB Stock Holding History

EA Series Trust’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$430K Buy
+1,510
New +$449K 0.02% 863

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

EA Series Trust's BIIB Position: Q2 2023 in Review

EA Series Trust opened a new position in Biogen (BIIB) in Q2 2023: 1,510 shares worth $430K. The stake represents 0.02% of the portfolio and ranks #863 among its holdings.

1,008 funds tracked by Wall St. Rank hold BIIB as of Q2 2023.

  • EA Series Trust held 1,510 shares of Biogen worth $430K as of Q2 2023.
  • Biogen was a new EA Series Trust position in Q2 2023.
  • Biogen made up 0.02% of EA Series Trust's portfolio in Q2 2023, its #863 holding.
  • 1,008 funds tracked by Wall St. Rank held Biogen as of Q2 2023.

Based on EA Series Trust's 13F filing for Q2 2023, filed 27 Jul 2023.